Literature DB >> 12391926

Early discharge after core liver biopsy: is it safe and cost-effective?

Simon G Bicknell1, Jonathon Richenberg, Peter L Cooperberg, Pari Tiwari, Laurence Halperin.   

Abstract

OBJECTIVE: To determine if ambulatory patients who have undergone image-guided core liver biopsy with an 18-gauge needle and spring-loaded biopsy gun can be safely discharged after 1 hour of observation in the radiology department.
METHODS: Fifty-four consecutive patients underwent ultrasound-guided core liver biopsy for a variety of suspected diffuse liver diseases. Post-biopsy, they were asked to grade their pain on a scale of 1-10 after 1 hour of recumbency on a hospital gurney in the department. At 2 weeks, all patients were contacted and asked about their level of pain and when they returned to normal activities.
RESULTS: Of the 54 patients enrolled, 4 were lost to follow-up. Pain was the most common minor complication, occurring in 31 (62%) of patients. The average level of pain after 1 hour was 2.1 (1 = no pain) and after 24 hours, 1.5. Seven patients were admitted to a medical daycare bed for a total of 4 hours and were then discharged. The remainder were discharged after 1 hour. Forty (80%) patients were pain-free after 24 hours, 36 (90%) of the 40 patients who were working returned to work the following day, and within a week, all patients had returned to all normal activities. No patients required an inpatient hospital stay or sought assistance at an emergency department.
CONCLUSION: These preliminary results demonstrate that ultrasound-guided 18-gauge liver core biopsy is a safe procedure, and, provided larger series confirm these findings, patients showing no complications can be discharged from the department after 1 hour with notable cost savings.

Entities:  

Mesh:

Year:  2002        PMID: 12391926

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  3 in total

1.  Outpatient liver biopsy: a prospective evaluation of 500 cases.

Authors:  P Beddy; I L Lyburn; T Geoghegan; O Buckley; A R Buckley; W C Torreggiani
Journal:  Gut       Date:  2006-10-06       Impact factor: 23.059

2.  The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies.

Authors:  Jee-Fu Huang; Ming-Yen Hsieh; Chia-Yen Dai; Nai-Jen Hou; Li-Po Lee; Zu-Yau Lin; Shinn-Chern Chen; Liang-Yen Wang; Ming-Yuh Hsieh; Wen-Yu Chang; Ming-Lung Yu; Wan-Long Chuang
Journal:  Gut       Date:  2007-05       Impact factor: 23.059

3.  Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology.

Authors:  James Neuberger; Jai Patel; Helen Caldwell; Susan Davies; Vanessa Hebditch; Coral Hollywood; Stefan Hubscher; Salil Karkhanis; Will Lester; Nicholas Roslund; Rebecca West; Judith I Wyatt; Mathis Heydtmann
Journal:  Gut       Date:  2020-05-28       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.